Hypobaric hypoxia (HH) leads to reduced oxygen delivery to brain. It could trigger cognitive dysfunction and increase the risk of dementia including Alzheimer’s disease (AD). The present study was undertaken in order to examine whether B vitamins (B6, B12, folate, and choline) could exert protective effects on hypoxia-induced memory deficit and AD related molecular events in mice. Adult male Kunming mice were assigned to five groups: normoxic control, hypoxic model (HH), hypoxia+vitamin B6/B12/folate (HB), hypoxia+choline (HC), hypoxia+vitamin B6/B12/folate+choline (HBC). Mice in the hypoxia, HB, HC, and HBC groups were exposed to hypobaric hypoxia for 8 h/day for 28 days in a decompression chamber mimicking 5500 meters of high altitude. Spatial and passive memories were assessed by radial arm and step-through passive test, respectively. Levels of tau and glycogen synthase kinase (GSK)-3β phosphorylation were detected by western blot. Homocysteine (Hcy) concentrations were determined using enzymatic cycling assay. Mice in the HH group exhibited significant spatial working and passive memory impairment, increased tau phosphorylation at Thr181, Ser262, Ser202/Thr205, and Ser396 in the cortex and hippocampus, and elevated Hcy levels compared with controls. Concomitantly, the levels of Ser9-phosphorylated GSK-3β were significantly decreased in brain after hypoxic treatment. Supplementations of vitamin B6/B12/folate+choline could significantly ameliorate the hypoxia-induced memory deficits, observably decreased Hcy concentrations in serum, and markedly attenuated tau hyperphosphorylation at multiple AD-related sites through upregulating inhibitory Ser9-phosphorylated GSK-3β. Our finding give further insight into combined neuroprotective effects of vitamin B6, B12, folate, and choline on brain against hypoxia.
ChampodAS, EskesGA, FosterGE, HanlyPJ, PialouxV, BeaudinAE, PoulinMJ (2013) Effects of acute intermittent hypoxia on working memory in young healthy adults. Am J Respir Crit Care Med187, 1148–1150.
3.
MalleC, QuinetteP, LaisneyM, BourrilhonC, BoissinJ, DesgrangesB, EustacheF, PierardC (2013) Working memory impairment in pilots exposed to acute hypobaric hypoxia. Aviat Space Environ Med84, 773–779.
4.
MichielsC (2004) Physiological and pathological responses to hypoxia. Am J Pathol164, 1875–1882.
5.
YaffeK, LaffanAM, HarrisonSL, RedlineS, SpiraAP, EnsrudKE, Ancoli-IsraelS, StoneKL (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA306, 613–619.
6.
SavvaGM, StephanBC (2010) Epidemiological studies of the effect of stroke on incident dementia: A systematic review. Stroke41, e41–e46.
7.
LiuH, LeW (2014) Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease. Transl Neurodegener3, 7.
8.
ZhangX, LeW (2010) Pathological role of hypoxia in Alzheimer’s disease. Exp Neurol223, 299–303.
9.
FangH, ZhangLF, MengFT, DuX, ZhouJN (2010) Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci Lett474, 173–177.
10.
ZhangCE, YangX, LiL, SuiX, TianQ, WeiW, WangJ, LiuG (2014) Hypoxia-induced tau phosphorylation and memory deficit in rats. Neurodegener Dis14, 107–116.
11.
Grundke-IqbalI, IqbalK, TungYC, QuinlanM, WisniewskiHM, BinderLI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A83, 4913–4917.
12.
SwerdlowRH (2007) Pathogenesis of Alzheimer’s disease. Clin Interv Aging2, 347–359.
13.
HuttonM, LendonCL, RizzuP, BakerM, FroelichS, HouldenH, Pickering-BrownS, ChakravertyS, IsaacsA, GroverA, HackettJ, AdamsonJ, LincolnS, DicksonD, DaviesP, PetersenRC, StevensM, de GraaffE, WautersE, van BarenJ, HillebrandM, JoosseM, KwonJM, NowotnyP, CheLK, NortonJ, MorrisJC, ReedLA, TrojanowskiJ, BasunH, LannfeltL, NeystatM, FahnS, DarkF, TannenbergT, DoddPR, HaywardN, KwokJB, SchofieldPR, AndreadisA, SnowdenJ, CraufurdD, NearyD, OwenF, OostraBA, HardyJ, GoateA, van SwietenJ, MannD, LynchT, HeutinkP (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature393, 702–705.
JohnsonGV, StoothoffWH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci117, 5721–5729.
16.
PlattnerF, AngeloM, GieseKP (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem281, 25457–25465.
17.
MorrisMS (2012) The role of B vitamins in preventing and treating cognitive impairment and decline. Adv Nutr3, 801–812.
18.
KamatPK, VacekJC, KalaniA, TyagiN (2015) Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer’s Disease Etiology. Open Neurol J9, 9–14.
19.
Van DamF, Van GoolWA (2009) Hyperhomocysteinemia and Alzheimer’s disease: A systematic review. Arch Gerontol Geriatr48, 425–430.
20.
MorrisMS (2003) Homocysteine and Alzheimer’s disease. Lancet Neurol2, 425–428.
21.
SeshadriS, BeiserA, SelhubJ, JacquesPF, RosenbergIH, D’AgostinoRB, WilsonPW, WolfPA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med346, 476–483.
22.
WeiW, LiuYH, ZhangCE, WangQ, WeiZ, MousseauDD, WangJZ, TianQ, LiuGP (2011) Folate/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyperphosphorylation and memory deficits in aged rats. J Alzheimers Dis27, 639–650.
23.
CohenBM, RenshawPF, StollAL, WurtmanRJ, Yurgelun-ToddD, BabbSM (1995) Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA274, 902–907.
24.
NitschRM, BlusztajnJK, PittasAG, SlackBE, GrowdonJH, WurtmanRJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A89, 1671–1675.
25.
LockmanPR, AllenDD (2002) The transport of choline. Drug Dev Ind Pharm28, 749–771.
26.
CohenEL, WurtmanRJ (1976) Brain acetylcholine: Control by dietary choline. Science191, 561–562.
27.
GarnerSC, MarMH, ZeiselSH (1995) Choline distribution and metabolism in pregnant rats and fetuses are influenced by the choline content of the maternal diet. J Nutr125, 2851–2858.
28.
van WijkN, BroersenLM, de WildeMC, HagemanRJ, GroenendijkM, SijbenJW, KamphuisPJ (2014) Targeting synaptic dysfunction in Alzheimer’s disease by administering a specific nutrient combination. J Alzheimers Dis38, 459–479.
29.
van WijkN, WatkinsCJ, BohlkeM, MaherTJ, HagemanRJ, KamphuisPJ, BroersenLM, WurtmanRJ (2012) Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets. Br J Nutr107, 1408–1412.
30.
NiculescuMD, ZeiselSH (2002) Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline. J Nutr132, 2333S–2335S.
31.
ChenCC, ShenJW, ChungNC, MinMY, ChengSJ, LiuIY (2012) Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel. PLoS One7, e29384.
32.
ChenY, YuLX, HongY, NiuC, GaoJW, JinH, WangXL, WangH (2014) [Effect of hypobaric hypoxia exposure on memory and tau phosphorylation in brain of mice]. Zhongguo Ying Yong Sheng Li Xue Za Zhi30, 285–288.
DengY, GuoXL, YuanX, ShangJ, ZhuD, LiuHG (2015) P2X7 receptor antagonism attenuates the intermittent hypoxia-induced spatial deficits in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress. Chin Med J (Engl)128, 2168–2175.
35.
SteinhilbML, Dias-SantagataD, FulgaTA, FelchDL, FeanyMB (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell18, 5060–5068.
36.
BallatoreC, LeeVM, TrojanowskiJQ (2007) Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci8, 663–672.
37.
SharmaVK, DasSK, DharP, HotaKB, MahapatraBB, VashishthaV, KumarA, HotaSK, NorbooT, SrivastavaRB (2014) Domain specific changes in cognition at high altitude and its correlation with hyperhomocysteinemia. PLoS One9, e101448.
38.
DharP, SharmaVK, HotaKB, DasSK, HotaSK, SrivastavaRB, SinghSB (2014) Autonomic cardiovascular responses in acclimatized lowlanders on prolonged stay at high altitude: A longitudinal follow up study. PLoS One9, e84274.
39.
LiJG, ChuJ, BarreroC, MeraliS, PraticoD (2014) Homocysteine exacerbates beta-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles. Ann Neurol75, 851–863.
40.
ZhangCE, TianQ, WeiW, PengJH, LiuGP, ZhouXW, WangQ, WangDW, WangJZ (2008) Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging29, 1654–1665.
41.
DaCA, HornAP, HoppeJB, GrudzinskiPB, LoureiroSO, FerreiraAG, DaCM, SchmitzF, SalbegoCG, WyseAT (2012) Evidence that AKT and GSK-3beta pathway are involved in acute hyperhomocysteinemia. Int J Dev Neurosci30, 369–374.
42.
ReynoldsCH, BettsJC, BlackstockWP, NebredaAR, AndertonBH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem74, 1587–1595.
McCannJC, HudesM, AmesBN (2006) An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring. Neurosci Biobehav Rev30, 696–712.
45.
ZeiselSH (2006) The fetal origins of memory: The role of dietary choline in optimal brain development. J Pediatr149, S131–S136.
46.
FisherMC, ZeiselSH, MarMH, SadlerTW (2002) Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J16, 619–621.
47.
ClarkeR, SmithAD, JobstKA, RefsumH, SuttonL, UelandPM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol55, 1449–1455.
48.
DaCK, GaffneyCE, FischerLM, ZeiselSH (2005) Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am J Clin Nutr81, 440–444.
